SCHEMBL4350079

SCHEMBL4350079

Cc1ccc(CNC2=NC(=O)/C(=C/c3cccc4ccccc34)S2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
MAPT P10636 4/20 0.55
ALDH1A1 P00352 3/20 0.55
POLB P06746 2/20 0.55
GLA P06280 1/20 0.55
HTT P42858 1/20 0.55
AKR1B1 P15121 3/20 0.42
MEN1 O00255 3/20 0.42
TTR P02766 1/20 0.42
PIM1 P11309 1/20 0.40
PTPN1 P18031 2/20 0.39
ALOX5 P09917 4/20 0.39
APP P05067 2/20 0.38
HPGD P15428 2/20 0.36
CTSL P07711 1/20 0.36
ACP1 P24666 1/20 0.36
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350081 1.00 KMT2A (0.55) KMT2AMAPTALDH1A1POLBGLA
SCHEMBL4348120 0.86 MAPT (0.49) KMT2AMAPTALDH1A1POLBGLA
SCHEMBL4348118 0.86 MAPT (0.49) KMT2AMAPTALDH1A1POLBGLA
SCHEMBL4355388 0.82 KDM4E (0.47) KMT2AMAPTALDH1A1POLBGLA
SCHEMBL4355386 0.82 KDM4E (0.47) KMT2AMAPTALDH1A1POLBGLA
SCHEMBL4350505 0.80 ALOX5 (0.49) KMT2AMAPTALDH1A1HTTMEN1
SCHEMBL4350510 0.80 ALOX5 (0.49) KMT2AMAPTALDH1A1HTTMEN1
SCHEMBL4348504 0.75 ALOX5 (0.54) AKR1B1PTPN1ALOX5HPGDACP1
SCHEMBL4348499 0.75 ALOX5 (0.54) AKR1B1PTPN1ALOX5HPGDACP1
SCHEMBL4350295 0.75 ALOX5 (0.52) MAPTALDH1A1AKR1B1PTPN1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP claimed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP disclosed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 KMT2A 3923/4885MAPT 1470/4885ALDH1A1 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.